Evidence map›Paper›PMID 37069201›Full record

ArticleScientific reports2023

Toxicological assessment of Phormidium sp. derived copper oxide nanoparticles for its biomedical and environmental applications.

Nida Asif, Rakhshan Ahmad, Samreen Fatima, Shehzadi Shehzadi, Tabassum Siddiqui, Almaz Zaki, Tasneem Fatma

Abstract read
In one paragraph

Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Biofabrication of Silver Nanoparticles UsingInternational journal of nanomedicine · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Nida AsifDepartment of Biosciences, Jamia Millia Islamia, Jamia Nagar, New Delhi, 110025, India.
Rakhshan AhmadDepartment of Biosciences, Jamia Millia Islamia, Jamia Nagar, New Delhi, 110025, India.
Samreen FatimaDepartment of Biosciences, Jamia Millia Islamia, Jamia Nagar, New Delhi, 110025, India.
Shehzadi ShehzadiDepartment of Biosciences, Jamia Millia Islamia, Jamia Nagar, New Delhi, 110025, India.
Tabassum SiddiquiDepartment of Biosciences, Jamia Millia Islamia, Jamia Nagar, New Delhi, 110025, India.
Almaz ZakiDepartment of Biotechnology, Jamia Millia Islamia, New Delhi, 110025, India.
Tasneem FatmaDepartment of Biosciences, Jamia Millia Islamia, Jamia Nagar, New Delhi, 110025, India. fatma_cbl@yahoo.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Driven by the need to biosynthesized alternate biomedical agents to prevent and treat infection, copper oxide nanoparticles (CuONPs) have surfaced as a promising avenue. Cyanobacteria-derived synthesis of CuONPs is of substantive interest as it offers an eco-friendly, cost-effective, and biocompatible route. In the present study biosynthesized CuONPs were characterized and investigated regarding their toxicity. Morphological analysis using TEM, SEM and AFM showed the spherical particle size of 20.7 nm with 96% copper that confirmed the purity of CuONPs. Biogenic CuONPs with IC

Indexed as

Carcinoma, Non-Small-Cell LungLung NeoplasmsMetal NanoparticlesNanoparticlesCandida albicansCopperHumansPhormidiumSuperoxidesCoppercuprous oxideSuperoxides

Identifiers

PMID37069201
PMCPMC10110551

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.